Impact of high-dose peginterferon alfa-2A on virological response rates in patients with hepatitis C genotype 1: a randomized controlled trial (Q42990123)

From Wikidata

Jump to navigation Jump to search

scientific article published on October 2009

Language	Label	Description	Also known as
English	Impact of high-dose peginterferon alfa-2A on virological response rates in patients with hepatitis C genotype 1: a randomized controlled trial	scientific article published on October 2009

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Impact of high-dose peginterferon alfa-2A on virological response rates in patients with hepatitis C genotype 1: a randomized controlled trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

0 references

peginterferon alfa-2a

1 reference

based on heuristic

inferred from title

William D. Rawlinson

7

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

13

object named as

Gregory J Dore

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

author name string

Stuart K Roberts

1

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Martin D Weltman

2

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Darrell H G Crawford

3

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Geoffrey W McCaughan

4

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

William Sievert

5

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Wendy S Cheng

6

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Paul V Desmond

8

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Phillipa S Marks

9

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Motoko Yoshihara

10

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Bishoy Rizkalla

11

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Jean K Depamphilis

12

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Chariot Study Group

14

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

language of work or name

0 references

publication date

1 October 2009

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

50

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

1045-1055

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23130

21 January 2018

Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23130

21 January 2018

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23130

21 January 2018

Combination of interferon induction therapy and ribavirin in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23130

21 January 2018

Peginterferon alfa-2b plus ribavirin for naïve patients with genotype 1 chronic hepatitis C: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23130

21 January 2018

Effect of combined interferon-alpha induction therapy and ribavirin on chronic hepatitis C virus infection: a randomized multicentre study

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23130

21 January 2018

Induction therapy with consensus interferon (CIFN) does not improve sustained virologic response in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23130

21 January 2018

Daily induction combination treatment with alpha 2b interferon and ribavirin or standard combination treatment in naive chronic hepatitis C patients. A multicentre randomized controlled trial

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23130

21 January 2018

Early viral clearance and sustained response in chronic hepatitis C: a controlled trial of interferon and ribavirin after high-dose interferon induction.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23130

21 January 2018

Hepatitis C virus RNA levels during initial induction or standard interferon therapy: influence of continued treatment on sustained response

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23130

21 January 2018

Viral kinetics in patients with chronic hepatitis C treated with standard or peginterferon alpha2a

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23130

21 January 2018

Estimation of early hepatitis C viral clearance in patients receiving daily interferon and ribavirin therapy using a mathematical model

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23130

21 January 2018

Predicting sustained virological responses in chronic hepatitis C patients treated with peginterferon alfa-2a (40 KD)/ribavirin

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23130

21 January 2018

Early identification of HCV genotype 1 patients responding to 24 weeks peginterferon alpha-2a (40 kd)/ribavirin therapy

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23130

21 January 2018

Extended treatment duration for hepatitis C virus type 1: comparing 48 versus 72 weeks of peginterferon-alfa-2a plus ribavirin

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23130

21 January 2018

Peginterferon alfa-2a and ribavirin for 24 weeks in hepatitis C type 1 and 4 patients with rapid virological response

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23130

21 January 2018

Quantification of the initial decline of serum hepatitis C virus RNA and response to interferon alfa

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23130

21 January 2018

Early virologic response to treatment with peginterferon alfa-2b plus ribavirin in patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23130

21 January 2018

Identifiers

10.1002/HEP.23130

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42990123&oldid=1975918774"